Rare diseases
Investigational molecules
Locations
Back to Bulgaria78 clinical trials in Veliko Tirnovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaBulgariaStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
BulgariaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
BulgariaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
BulgariaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
BulgariaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
BulgariaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Research includes evaluation of new medications for reducing cardiovascular events and managing blood lipid levels.
Trials are investigating novel approaches to cholesterol management and prevention of major adverse cardiovascular events.
Advanced research into chronic obstructive pulmonary disease (COPD) treatments and respiratory infections. Studies evaluate new therapeutic combinations and treatment efficacy.
Focus on developing improved inhalation therapies and testing new drug formulations for respiratory conditions.
Innovative research in treating ulcerative colitis and inflammatory bowel conditions. Multiple trials exploring combination therapies and long-term treatment options.
Emphasis on developing sustainable treatment approaches for chronic gastrointestinal conditions.
Comprehensive studies on major depressive disorder and other psychiatric conditions. Investigation of new therapeutic approaches for mental health management.
Focus on long-term safety and efficacy of new psychiatric medications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
